STRS Ohio’s Kindred Biosciences, Inc. KIN Stock Holding History

STRS Ohio’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-39,500	Closed	-$341K	–	2252
2019 Q1	$362K	Hold	39,500	–	–	﹤0.01%	1468
2018 Q4	$432K	Buy	39,500 +10,483	+36%	+$132K	﹤0.01%	1334
2018 Q3	$404K	Buy	+29,017	New	+$393K	﹤0.01%	1479
2014 Q3	–	Sell	-1,400	Closed	-$18.9K	–	1848
2014 Q2	$26K	Sell	1,400 -1,800	-56%	-$30.6K	﹤0.01%	1653
2014 Q1	$59K	Buy	+3,200	New	+$61K	﹤0.01%	1602

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

STRS Ohio's KIN Position: Q2 2019 in Review

STRS Ohio sold out of Kindred Biosciences, Inc. (KIN) in Q2 2019, closing a stake of 39,500 shares — an estimated $341K sold.

STRS Ohio first reported a position in KIN in Q1 2014 and held it in 5 quarters. The position peaked at $432K in Q4 2018. 75 funds tracked by Wall St. Rank hold KIN as of Q2 2019.

STRS Ohio reported no remaining Kindred Biosciences, Inc. position as of Q2 2019 after selling out during the quarter.
STRS Ohio sold 39,500 Kindred Biosciences, Inc. shares in Q2 2019, an estimated $341K.
STRS Ohio first reported a position in Kindred Biosciences, Inc. in Q1 2014 and held it in 5 quarters.
STRS Ohio's Kindred Biosciences, Inc. position peaked at $432K in Q4 2018.
75 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2019.

Based on STRS Ohio's 13F filing for Q2 2019, filed 25 Jul 2019.